The murine homolog of the human breast and ovarian cancer susceptibility gene Brca1 maps to mouse chromosome 11D

被引:14
作者
Schrock, E
Badger, P
Larson, D
Erdos, M
WynshawBoris, A
Ried, T
Brody, L
机构
[1] NIH,NATL CTR HUMAN GENOME RES,LAB GENE TRANSFER,BETHESDA,MD 20892
[2] NIH,NATL CTR HUMAN GENOME RES,DIAGNOST DEV BRANCH,BETHESDA,MD 20892
[3] NIH,NATL CTR HUMAN GENOME RES,LAB GENET DIS RES,BETHESDA,MD 20892
关键词
D O I
10.1007/BF02265277
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The recently cloned human breast and ovarian cancer suseptibility gene, BRCA1, is located on human chromosome 17q21. We have isolated murine genomic clones containing Brca1 as a first step in generating a mouse model for the loss of BRCA1 function. A mouse genomic library was screened using probes corresponding to exon 11 of the human BRCA1 gene. Two overlapping mouse clones were identified that hybridized to human BRCA1 exons 9-12. Sequence analysis of 1.4 kb of the region of these clones corresponding to part of human exon 11 revealed 72% nucleic acid identity but only 50% amino acid identity with the human gene. The longest of the mouse Brcal genomic clones maps to chromosome 11D, as determined by two-color fluorescence in situ hybridization. The synteny to human chromosome 17 was confirmed by cohybridization with the mouse probe for the NF1-gene. This comparative study confirms that the relative location of the BRCA1 gene has been conserved between mice and humans.
引用
收藏
页码:256 / 259
页数:4
相关论文
共 50 条
  • [31] Implication of BRCA1 gene in breast cancer
    Kachhap, S.K.
    Ghosh, S.N.
    Indian Journal of Experimental Biology, 2001, 39 (05) : 391 - 400
  • [32] Mutational analysis of BRCA1 gene in ovarian and breast-ovarian cancer families in Japan
    Takano, M
    Aida, H
    Tsuneki, I
    Takakuwa, K
    Hasegawa, I
    Tanaka, H
    Saito, M
    Tsuji, S
    Sonoda, T
    Hatae, M
    Chen, JT
    Takahashi, K
    Hasegawa, K
    Toyoda, N
    Saito, N
    Yakushiji, M
    Araki, T
    Tanaka, K
    JAPANESE JOURNAL OF CANCER RESEARCH, 1997, 88 (04): : 407 - 413
  • [33] Germline mutations in cancer susceptibility genes in BRCA1 and BRCA2 negative families with ovarian and breast cancer
    Norquist, B.
    Harrell, M.
    Walsh, T.
    Mandell, J.
    Bernards, S.
    Agnew, K.
    Lee, M.
    Pennington, K.
    King, M. C.
    Swisher, E.
    CLINICAL CANCER RESEARCH, 2015, 21
  • [34] BRCA1 and BRCA2 and the genetics of breast and ovarian cancer
    Welcsh, PL
    King, MC
    HUMAN MOLECULAR GENETICS, 2001, 10 (07) : 705 - 713
  • [35] Germline mutations in cancer susceptibility genes in brca1 and brca2 negative families with ovarian and breast cancer
    Norquist, B.
    Harrell, M.
    Walsh, T.
    Mandell, J.
    Agnew, K.
    Lee, M.
    Pennington, K.
    King, M. C.
    Swisher, E.
    GYNECOLOGIC ONCOLOGY, 2014, 135 (02) : 383 - 383
  • [36] Breast cancer susceptibility genes -: BRCA1 and BRCA2
    Brody, LC
    Biesecker, BB
    MEDICINE, 1998, 77 (03) : 208 - 226
  • [37] Regression of Acoustic Tumor After Chemotherapy for Ovarian Cancer in a Patient With a Breast Cancer Susceptibility Gene 1 (BRCA1) Germline Mutation
    Takeda, Anna
    Kobayashi, Masahito
    Hasegawa, Kosei
    Fujimaki, Takamitsu
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (03)
  • [40] Testing for the BRCA1 and BRCA2 breast-ovarian cancer susceptibility genes: A decision analysis
    Tengs, TO
    Winer, EP
    Paddock, S
    Aguilar-Chavez, O
    Berry, DA
    MEDICAL DECISION MAKING, 1998, 18 (04) : 365 - 375